PASAT in Detecting Cognitive Impairment in Relapsing-Remitting MS
PASAT in Detecting Cognitive Impairment in Relapsing-Remitting MS
复制标题
PASAT 用于检测复发缓解型多发性硬化症的认知障碍
DOI:
10.1080/09084280701319938
复制
发表时间:
2007
影响因子:
--
通讯作者:
L. Hokkanen
中科院分区:
文献类型:
--
作者:
E. Rosti;P. Hämäläinen;K. Koivisto;L. Hokkanen
The PASAT, as a part of the Multiple Sclerosis Functional Composite, is used as a sole measure of cognition in multiple sclerosis (MS) clinical trials. In the present study, we evaluated the frequency and characteristics of cognitive impairment among relapsing-remitting MS patients. Using a comprehensive neuropsychological examination as the “golden standard,” we assessed PASAT's sensitivity and specificity in MS-related cognitive impairment as well as factors possibly confounding PASAT performance. Forty-five relapsing-remitting MS patients and 48 healthy controls were studied using PASAT and a comprehensive neuropsychological examination. The frequency of cognitive dysfunction among MS patients was 42%. Cognitive impairment in MS was heterogeneous in nature but characterized, especially, by reduced information-processing ability and memory deficits. PASAT's sensitivity for patients' cognitive impairment was 74% and specificity 65%. Misclassification of cognitive impairment seemed to be associated with self-reported nervousness and poor arithmetic skills. Although PASAT offers satisfactory sensitivity in detecting the presence of cognitive impairment, its specificity may be limited by confounding factors.
影响因子:
11.2
作者:
Fischer,JS;Priore,RL;Jacobs,LD;Cookfair,DL;Rudick,RA;Herndon,RM;Richert,JR;Salazar,AM;Goodkin,DE;Granger,CV;Simon,JH;Grafman,JH;Lezak,MD;O'ReillyHovey,KM;Perkins,KK;Barilla-Clark,D;Schacter,M;Shucard,DW;
通讯作者:
--